News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Taylor Beth
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/21/2023 |
4
| Taylor Beth (CFO) has filed a Form 4 on Inotiv, Inc.|
Txns:
| Granted 5,000 shares
@ $0 |
|
| 01/20/2023 |
4
| Taylor Beth (CFO) has filed a Form 4 on Inotiv, Inc.|
Txns:
| Granted 5,917 shares
@ $0 |
|
| 02/22/2022 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on Inotiv, Inc.|
Txns:
| Bought 5,000 shares
@ $23.0715, valued at
$115.4k
|
|
| 02/17/2022 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on Inotiv, Inc.|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2021 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on Inotiv, Inc.|
Txns:
| Granted 1,332 shares
@ $0 |
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2020 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on BIOANALYTICAL SYSTEMS INC|
Txns:
| Granted 5,995 shares
@ $0 |
|
| 06/11/2020 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on BIOANALYTICAL SYSTEMS INC|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 05/21/2020 |
4
| Taylor Beth (VP- Finance & CFO) has filed a Form 4 on BIOANALYTICAL SYSTEMS INC|
Txns:
| Bought 5,067 shares
@ $4.38, valued at
$22.2k
Bought 4,933 shares
@ $4.42, valued at
$21.8k
Bought 3,300 shares
@ $4.52, valued at
$14.9k
|
|
| 03/12/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/21/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Off) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Disposed/sold 59,509 shares
@ $24, valued at
$1.4M
Disposed/sold 1,250 shares
@ $24, valued at
$30k
Disposed/sold 1,875 shares
@ $24, valued at
$45k
Disposed/sold 7,500 shares
@ $24, valued at
$180k
Disposed/sold 15,000 shares
@ $24, valued at
$360k
Disposed/sold 12,500 shares
@ $24, valued at
$300k
Disposed/sold 23,560 options to buy
@ $7.41, valued at
$174.6k
Disposed/sold 9,132 options to buy
@ $9.86, valued at
$90k
Disposed/sold 10,850 options to buy
@ $11.11, valued at
$120.5k
Disposed/sold 3,750 options to buy
@ $3.18, valued at
$11.9k
Disposed/sold 12,969 options to buy
@ $3.21, valued at
$41.6k
|
|
| 12/19/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Gifted 2,500 shares
@ $0
Gifted 1,250 shares
@ $0
Gifted 3,186 shares
@ $0
Gifted 1,250 shares
@ $0
Exercised 16,073 options to buy
@ $3.55, valued at
$57.1k
Exercised 5,500 options to buy
@ $9.86, valued at
$54.2k
Exercised 9,000 options to buy
@ $5.1, valued at
$45.9k
Exercised 3,750 options to buy
@ $3.18, valued at
$11.9k
Exercised 9,531 options to buy
@ $3.21, valued at
$30.6k
Exercised 5,000 options to buy
@ $2.16, valued at
$10.8k
|
|
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/29/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 7,892 shares
@ $20, valued at
$157.8k
|
|
| 08/22/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Sold 285 shares
@ $18.2001, valued at
$5.2k
|
|
| 02/08/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Paid exercise price by delivering 484 shares
@ $3, valued at
$1.5k
Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $3.01, valued at
$75.3k
|
|
| 02/06/2018 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Paid exercise price by delivering 890 shares
@ $3.12, valued at
$2.8k
Paid exercise price by delivering 869 shares
@ $3.12, valued at
$2.7k
|
|
| 10/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/22/2016 |
4
| Taylor Beth (VP Finance & Chief Acctg Offcr) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 3,750 shares
@ $0
Granted 22,500 options to buy
@ $3.21, valued at
$72.2k
|
|
| 02/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/02/2012 |
4
| Taylor Beth (Corporate Controller) has filed a Form 4 on ENDOCYTE INC|
Txns:
| Granted 16,073 options to buy
@ $3.55, valued at
$57.1k
|
|
| 06/03/2011 |
3
| Taylor Beth (Corporate Controller) has filed a Form 3 on ENDOCYTE INC |
|
|